2m 2m 2m 2m 2m 2m 2m
ROYAL PHARM -A (RPRX)
NASDAQ
$63.97+$0.11 (+0.17%)
Price as of Oct 23, 2026 7:54 PM EDT- $28.3BMarket Cap
- 74.71%1-Year Change
- BiotechnologyIndustry
ROYAL PHARM -A (RPRX)
$63.97+$0.11 (+0.17%)
RPRX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $63.86 | ||
Change | +$0.11 (+0.17%) | ||
Open | $63.50 | ||
High | $63.97 | ||
Low | $63.01 | ||
Previous Close | $63.75 | ||
Volume | 4,015,551 | ||
30-Day Average Volume | 3,017,787 | ||
1-Week Change | 4.76% | ||
1-Month Change | 10.77% | ||
1-Year Change | 74.71% | ||
3-Year Change | 151.80% | ||
5-Year Change | 91.40% | ||
Fundamentals | |||
Shares Outstanding | 443.2M | ||
Total Assets | $19.8B | ||
Market Cap | $28.3B | ||
Enterprise Value | $36.4B | ||
Period: QTR TTM FY | |||
Revenue | $638.0M | ||
Net Income | $17.9M | ||
Free Cash Flow | $728.5M | ||
EBIT | $17.9M | ||
EBITDA | $19.2M | ||
Net Working Capital | $1.1B | ||
EPS | $0.04 | ||
Enterprise Value/EBITDA | 1,898 | ||
Enterprise Value/Revenue | 57 | ||
P/B | 3 | ||
P/E | 1,597 | ||
PEG | -17 | ||
Price/Free Cash Flow | 39 | ||
Price/Operating Cash Flow | 39 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | 1.47% | ||
Trailing Annual Dividend Yield | 1.45% | ||
Ex-Dividend Date | 11/13/2026 | ||
Last Split Factor | 1 : 4 | ||
Last Split Date | 10/15/2010 | ||
Earnings & Revenue
Annual Dividend Yield